Completed PHASE4 INTERVENTIONAL 6-arm NCT01479075

The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism (Centrin)

Sponsor: German Diabetes Center

Conditions Diabetes

Interventions Placebo intransal insulin sham stimulation taVNS

Updated 8 times since 2017 Last updated: Jun 2, 2023 Started: Aug 31, 2011 Primary completion: Jan 31, 2014 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Diabetes and is currently completed. German Diabetes Center leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jul 2023 — Jul 2024 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jan 2021 — Jul 2023 [monthly]

Unknown Status PHASE4
Jun 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Active Not Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Jun 2019 [monthly]

Active Not Recruiting PHASE4
Jun 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE4

Status: Unknown Status → Active Not Recruiting
Jan 2017 — Jun 2017 [monthly]

Unknown Status PHASE4

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

German Diabetes Center

Data source: German Diabetes Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Düsseldorf, Germany